Red Light Therapy in Cosmetic Dermatology: Marketing Claims Backed by Evidence?

September 2026 | Volume 25 | Issue 9 | 793 | Copyright © September 2026


Published online September 2, 2026

doi:10.36849/JDD.9844

Natasha E. Barton BS BA,a Thu Anh Ly BS,B Gustavo Rodrigues de Moraes MS,c Aaron Wang MSc,a 
Nicole Case BA,a Robert P. Dellavalle MD PhD MSPH,d Cory A. Dunnick MDe  

aSchool of Medicine, University of Colorado School of Medicine, Aurora, CO
BRocky Vista University School of Osteopathic Medicine, Centennial, CO
cKansas City University College of Osteopathic Medicine, Kansas City, MO
dDepartment of Dermatology, University of Minnesota Medical School, Minneapolis, MN
eDermatology Service, Rocky Mountain Regional VAMC, Aurora, CO

Abstract
Background: Red light therapy (RLT) is a non-invasive modality that uses visible red wavelengths (approximately 620–700 nm) to modulate cellular activity. By stimulating mitochondrial cytochrome c oxidase, RLT increases adenosine triphosphate production, regulates reactive oxygen species, and activates downstream pathways involved in inflammation control, tissue repair, and collagen synthesis. RLT has rapidly expanded into cosmetic dermatology and consumer wellness markets with widespread direct-to-consumer marketing. This review synthesizes current evidence on the mechanisms and cosmetic applications with particular attention to discrepancies between peer-reviewed data and commercial claims.
Methods: The 6 most frequently targeted conditions were selected for analysis. A PubMed search was conducted to identify peer-reviewed studies evaluating RLT for cosmetic dermatologic indications. For each condition, the available evidence was synthesized and compared with claims made by leading commercial RLT devices.
Results: Evidence supports RLT as a safe adjunctive therapy for select indications, including acne, androgenetic alopecia, mild photoaging, and wound healing, where modest and gradual improvements are observed with consistent, maintenance-based use. In contrast, marketing materials frequently exaggerate the speed, magnitude, and durability of clinical benefit, portraying RLT as a universal or transformative solution.
Conclusion: RLT represents a biologically plausible and low-risk adjunct in cosmetic dermatology, but current consumer-facing narratives often exceed the available evidence.

J Drugs Dermatol. 2026;25(9): doi:10.36849/JDD.9844

INTRODUCTION

Red light therapy (RLT), also known as low-level light therapy (LLLT) or photobiomodulation (PBM), is a non-invasive technique using low-wavelength visible red light (620–700 nm) to modulate cellular activity.1 RLT delivers low-energy light that avoids thermal injury while stimulating mitochondrial cytochrome C oxidase, increasing adenosine triphosphate (ATP) production, modulating reactive oxygen species (ROS), and activating transcription factors involved in repair, anti-inflammatory signaling, and collagen synthesis.2,3

Originally studied in the 1960s and 1970s for wound healing and ulcer treatment, RLT has undergone a significant evolution.4 Today, it has emerged as a cornerstone of non-invasive rejuvenation strategies. Its transition from a niche medical intervention to a mainstream wellness and beauty modality has been driven by scientific curiosity, public interest in non-pharmaceutical skin solutions, and aggressive commercialization.5

Over the last decade, RLT has become widely available through both professional treatments and at-home light-emitting diode (LED) devices. Celebrity endorsements, social media promotion, and aesthetics marketing have amplified claims that RLT can “heal the skin from within” or “biohack aging”.6 The American Academy of Dermatology (AAD) highlights potential benefits while cautioning certain populations and identifies RLT as a leading skincare trend in October 2024.7,8 Beauty companies now market LED masks, scalp caps, and handheld tools for targeted use, contributing to a rapidly growing global light-therapy market.9,10

Many marketed devices lean on scientific language without FDA clearance or independent validation, creating tension between evidence-based dermatologic practice and direct-to-consumer narratives. This review synthesizes current knowledge on RLT mechanisms, cosmetic uses, efficacy, and marketing to clarify where evidence supports clinical application, and where claims outpace the data.

Close Menu